INTERNATIONAL PATENT: LETO LABORATORIES CO., LTD., 北京志道生物科技有限公司 FILES APPLICATION FOR "COMBINED COMPOSITION OF MODIFIED CYTOKINE AND CD40 AGONIST AND ANTI-TUMOR USE THEREOF"

GENEVA, Feb. 15 -- LETO LABORATORIES CO., LTD. (Building 4, Beilun Industrial Park, 9 North Yongteng Road,Haidian District, Beijing 100094), 北京志道生物科技有限公司 (中国北京市海淀区永腾北路9号院贝伦产业园4号楼) filed a patent application (PCT/CN2024/110558) for "COMBINED COMPOSITION OF MODIFIED CYTOKINE AND CD40 AGONIST AND ANTI-TUMOR USE THEREOF" on Aug 08, 2024. With publication no. WO/2025/031434, the details related to the patent application was published on Feb 13, 2025.

Notably, the patent application was submitted under the Internationa...